The recombinant GBV-C/HGV NS3 protein was expressed in Sf9 insect cells and analyzed by SDS-PAGE. A protein band about Mr 43810 was demonstrated on polyacrylamide gel electrophoresis and this protein amounted to more ...The recombinant GBV-C/HGV NS3 protein was expressed in Sf9 insect cells and analyzed by SDS-PAGE. A protein band about Mr 43810 was demonstrated on polyacrylamide gel electrophoresis and this protein amounted to more than 30% of the total cell proteins. Recombinant NS3 protein was purified by Ni-NTA column. Western blot showed that this recombinant protein could react with GBV-C/HGV RNA positive mixed sera. The recombinant GBV-C/HGV NS3 protein could be used to detect GBV-C/HGV infection and will supply material for study of structure and function of this protein.展开更多
Human μ-opioid receptor （HμOR） with a tag of six consecutive histidines at its carboxyl terminus had been expressed in recombinant baculovirus infected Sf9 insect cells.The maximal binding capacity for the [3H] di...Human μ-opioid receptor （HμOR） with a tag of six consecutive histidines at its carboxyl terminus had been expressed in recombinant baculovirus infected Sf9 insect cells.The maximal binding capacity for the [3H] diprenorphine and [3H]ohmefentanyl （Ohm） were 9.1± 0.7 and 6.52±0.23 nmol/g protein, respectively. The [3H] diprenorphine or [3H] Ohm binding to the receptor expressed in Sf9 cells was strongly inhibited by μ-selective agonists [D-Ala2], N-methylPhe4, glyol5]enkephalin （DAGO）, Ohm, and morphine, but neither by δ nor by K selective agonist. Na+ （100 mM） and GTP （50 μM） could reduce HμOR agonists etorphine and Ohm affinity binding to the overexpressed HμOR. μ-selective agonists DAGO and Ohm effectively stimulated [35S]GTPγS binding (EC50 = 2.7nM and 6.9 nM) and inhibited forskolin- stimulated cAMP accumulation (IC50 = 0.9 nM and 0.3 nM). The agonist-dependent effects could be blocked by opioid antagonist naloxone or by pretreatment of cells with pertussis toxin （PTX）. These results demonstrated that HμOR overexpressed in Sf9 insect cells functionally coupled to endogenous Gi/o proteins.展开更多
文摘The recombinant GBV-C/HGV NS3 protein was expressed in Sf9 insect cells and analyzed by SDS-PAGE. A protein band about Mr 43810 was demonstrated on polyacrylamide gel electrophoresis and this protein amounted to more than 30% of the total cell proteins. Recombinant NS3 protein was purified by Ni-NTA column. Western blot showed that this recombinant protein could react with GBV-C/HGV RNA positive mixed sera. The recombinant GBV-C/HGV NS3 protein could be used to detect GBV-C/HGV infection and will supply material for study of structure and function of this protein.
文摘Human μ-opioid receptor （HμOR） with a tag of six consecutive histidines at its carboxyl terminus had been expressed in recombinant baculovirus infected Sf9 insect cells.The maximal binding capacity for the [3H] diprenorphine and [3H]ohmefentanyl （Ohm） were 9.1± 0.7 and 6.52±0.23 nmol/g protein, respectively. The [3H] diprenorphine or [3H] Ohm binding to the receptor expressed in Sf9 cells was strongly inhibited by μ-selective agonists [D-Ala2], N-methylPhe4, glyol5]enkephalin （DAGO）, Ohm, and morphine, but neither by δ nor by K selective agonist. Na+ （100 mM） and GTP （50 μM） could reduce HμOR agonists etorphine and Ohm affinity binding to the overexpressed HμOR. μ-selective agonists DAGO and Ohm effectively stimulated [35S]GTPγS binding (EC50 = 2.7nM and 6.9 nM) and inhibited forskolin- stimulated cAMP accumulation (IC50 = 0.9 nM and 0.3 nM). The agonist-dependent effects could be blocked by opioid antagonist naloxone or by pretreatment of cells with pertussis toxin （PTX）. These results demonstrated that HμOR overexpressed in Sf9 insect cells functionally coupled to endogenous Gi/o proteins.
基金National major drug discovery "twelfth five-year" project "biological medicine drug patents expire large varieties of transformation" (No.2012ZX09202-301)Strategic emerging industry's core technology in guangdong province-antibody scale preparation of key technology R&D and tumor therapeutic antibody drugs (2012A080800008)+1 种基金Special major science and technology in guangdong province-development of a class of drugs for the treatment of malignant tumors of the anti AGR2 humanized monoclonal antibody 18A4HU (No.2012A080202014)Research development and Innovation Fund Project of Jinan University-CHO cell genome epigenetic mechanisms of regulation and its application in animal cell engineering (No.21612110)
